John N. Bonfiglio
Keine laufenden Positionen mehr
Profil
John N.
Bonfiglio formerly worked at Orchestra Therapeutics, Inc., as President & Chief Executive Officer from 2003 to 2005, Oragenics, Inc., as President, Chief Executive Officer & Director from 2011 to 2014, Argos Therapeutics, Inc., as President & Chief Executive Officer, Harrow, Inc., as President, Chief Executive Officer & Director from 2010 to 2011, Allergan, Inc., as Director-Business Planning, Baxter Healthcare Corp., as Director-Strategic Business Unit, GT Biopharma, Inc., as Director from 2018 to 2019, Marker Therapeutics, Inc., as President, Chief Operating Officer & Director from 2016 to 2017, Genprex, Inc., as Director in 2019, Microlin Bio, Inc., as Director, Microlin Bio, Inc., as Director, Cypress Bioscience, Inc., as Chief Operating Officer & Executive Vice President, and Qrons, Inc., as Chief Operating Officer in 2019.
Dr. Bonfiglio received his undergraduate degree in 1976 from Stony Brook University, Masters Business Admin degree in 1992 from Pepperdine University, doctorate degree from the University of California, Berkeley, and graduate degree in 1980 and doctorate degree in 1980 from the University of California San Diego.
Ehemalige bekannte Positionen von John N. Bonfiglio
| Unternehmen | Position | Ende |
|---|---|---|
| QRONS INC. | Geschäftsführer | 30.11.2019 |
| GENPREX, INC. | Direktor/Vorstandsmitglied | 10.06.2019 |
| GT BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 20.03.2019 |
| MARKER THERAPEUTICS, INC. | Präsident | 27.04.2017 |
| ORAGENICS, INC. | Vorstandsvorsitzender | 30.10.2014 |
Ausbildung von John N. Bonfiglio
| Stony Brook University | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
| University of California, Berkeley | Doctorate Degree |
| University of California San Diego | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| GT BIOPHARMA, INC. | Health Technology |
| MARKER THERAPEUTICS, INC. | Health Technology |
| ORAGENICS, INC. | Health Technology |
| GENPREX, INC. | Health Technology |
| HARROW, INC. | Health Technology |
| QRONS INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Orchestra Therapeutics, Inc.
 Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Finance |
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Health Technology |
Microlin Bio, Inc. /Old/
 Microlin Bio, Inc. /Old/ Medical SpecialtiesHealth Technology Microlin Bio, Inc. is a pre-clinical stage biopharmaceutical company. It focuses on the development of miR-based diagnostics and therapeutics, including both antimiRs and miR mimics, to diagnose and treat cancer. The company was founded by Joseph Hernandez on July 30, 2013 and is headquartered in New York, NY. | Health Technology |
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Microlin Bio, Inc.
 Microlin Bio, Inc. Pharmaceuticals: MajorHealth Technology Microlin Bio, Inc. is a biopharmaceutical company, which engages in the development of micro ribonucleic, acid therapeutics. It offers programs for cancer therapeutics and delivery platform technology. The company was founded by Joseph Hernandez on January 27, 2013 and is headquartered in Daly City, CA. | Health Technology |
